Immunocore (IMCR)
NASDAQ: IMCR
· Real-Time Price · USD
34.02
-0.06 (-0.18%)
At close: Sep 26, 2025, 3:59 PM
33.80
-0.65%
After-hours: Sep 26, 2025, 05:22 PM EDT
Immunocore Revenue Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 |
|---|---|---|---|
| Sale of Therapies Revenue | 97.96M | 93.88M | 84.05M |
| Sale of Therapies Revenue Growth | +4.35% | +11.69% | n/a |
Revenue by Geography
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 |
|---|---|---|---|---|---|
| Europe Revenue | 33.04M | 32.8M | 21.1M | 15.4M | 18.95M |
| Europe Revenue Growth | +0.73% | +55.48% | +36.96% | -18.72% | n/a |
| Rest Of World Revenue | 835K | 56.61M | 1.88M | 4.34M | 1.36M |
| Rest Of World Revenue Growth | -98.52% | +2907.81% | -56.61% | +217.96% | n/a |
| United States Revenue | 64.09M | n/a | 57.27M | 55.61M | 50.03M |
| United States Revenue Growth | n/a | n/a | +2.99% | +11.15% | n/a |
Operating Expense Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 42.79M | 40.2M | 42.32M | 35.53M | 38.64M | 39.29M | 44.37M | 13.37M | 45.6M | 41.16M | 43.14M | 25.88M | 24.51M | 20.11M | 24.37M | 20.05M | 23.8M | 20.18M | 14.17M | 9.71M | 12.25M | 9.61M | 8.57M |
| Selling, General, and Administrative Revenue Growth | +6.45% | -5.02% | +19.12% | -8.04% | -1.65% | -11.45% | +231.91% | -70.69% | +10.78% | -4.59% | +66.68% | +5.59% | +21.91% | -17.48% | +21.54% | -15.77% | +17.92% | +42.43% | +45.88% | -20.70% | +27.54% | +12.05% | n/a |
| Research and Development Revenue | 69.01M | 56.47M | 60.85M | 52.77M | 51.07M | 57.46M | 74.65M | 38.53M | 36.43M | 35.16M | 27.14M | 23.3M | 20.15M | 18.58M | 20.07M | 16.8M | 16.47M | 19.89M | 17.24M | 20.41M | 16.38M | 20.78M | 24.58M |
| Research and Development Revenue Growth | +22.21% | -7.20% | +15.31% | +3.32% | -11.12% | -23.03% | +93.74% | +5.77% | +3.59% | +29.58% | +16.47% | +15.64% | +8.44% | -7.43% | +19.49% | +1.99% | -17.17% | +15.32% | -15.51% | +24.61% | -21.18% | -15.45% | n/a |